saigonbao.com
Pharmaceutical Industry
Pharma digs in on changes it wants from Trump administration
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
Process digitization in the pharmaceutical industry: a lever for productivity and compliance
Pharma trends and predictions for 2025: An incoming CEO’s perspective
Pharma Market Forecast: Top Trends for Pharma in 2025
Ionis Pharmaceuticals EVP sells $213,889 in stock
Pharma’s Big Meeting in US Draws Protests Over Healthcare Costs
Purdue aims to speed evolution of pharma manufacturing in collaboration with Lilly and Merck
Drugs Licensed
AbbVie secures option to license Simcere's blood cancer drug candidate
Government picks 15 more prescription drugs for Medicare price negotiation
FDA Issues ACNU Final Rule Establishing New Requirements for Nonprescription Drugs with an Additional Condition for Nonprescription Use
Most online pharmacies are run illegally and could be selling dangerous or ineffective drugs, U.S. warns
Man admits selling unapproved drugs used in bodybuilding through Kalispell business
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
China's Simcere Pharma grants AbbVie option to license its blood cancer drug candidate
Drugs Patents
Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs
JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
Gilead, government settle HIV drug patent dispute
Litigators of the (Past) Week: Defending Against a $290M Claim and Scoring a $116M Win in Drug Patent Fight
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Gilead reportedly settles CDC patent dispute over HIV drugs
High Court Axes Edwards' Bid to Limit Drug-Patent Safe Harbor
Federal Circuit Upholds Validity of Entresto Patent In Precedential Decision Concerning Written Description and Enablement
Drugs Generics
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
US appeals court reinstates pause on generic version of Novartis' Entresto
Novartis Scrambles to Squelch Copycats as Generics Gain Ground
Biden administration picks 15 more drugs for Medicare negotiation
Report Reveals Billions Made from Generic Drug Price Hikes
Novartis wins 11th-hour bid to block generic version of blockbuster heart med Entresto
FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system
FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent
FDA Food and Drug Administration
Now that the FDA has banned red dye No. 3, what about more common food dyes?
Califf concludes 2nd FDA stint
Pharmaceutical Companies
Ionis Pharmaceuticals EVP Brian Birchler sells $176,580 in stock
Brian Thompson's boss: Pharma companies are "really responsible" for drug prices
Pharmaceutical companies spike EpiPen prices 600% while allegedly deceiving Hoosier consumers
Pharmaceutical companies conspired to spike EpiPen prices by 600%: lawsuit from Indiana Attorney General alleges
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential
Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
Is Recursion Pharmaceuticals Stock a Buy?
Process digitization in the pharmaceutical industry: a lever for productivity and compliance